Correlation analysis of red blood cell-platelet ratio and coagulation indicators. by Jie Zhao (49409)

Prognostic model for the red blood cell-platelet ratio and its trajectory categories during hospitalization. by Jie Zhao (49409)

R script used for modelling analyses. by Roland Proud (11764892)

Analysis of spatial overlap between the released red panda and the suitable habitat of local wild individuals. by Yanshan Zhou (14131359)

Snail count data. by Roland Proud (11764892)

Prognostic model for the red blood cell-platelet ratio and its trajectory categories during ICU stay. by Jie Zhao (49409)

CONSORT flow diagram depicting participant flow through the trial. by Leigh V. Evans (19753987)

Human parasitology infection intensity data. by Roland Proud (11764892)

Human parasitology prevalence data. by Roland Proud (11764892)

Prognostic Impact of Red Blood Cell-Platelet Ratio Trajectory Categories after PSM. by Jie Zhao (49409)

Summary of snail survey effort and count data. Occupancy and counts are given as area averages across site means, with associated site mean ranges given in brackets. Note that both... by Roland Proud (11764892)

Metabolic analysis of cecal contents. by Ye Cheng (513097)

Rut inhibited the degradation of TJPs to reduce BBB breakdown and also suppressed apoptosis of brain tissue cells. by Zhixuan Huang (6750410)

The red blood cell-platelet ratio affects prognosis. by Jie Zhao (49409)

Red blood cell-platelet ratio and HR-restriction cube diagram during hospitalization. by Jie Zhao (49409)

Impact of red blood cell-platelet ratio trajectories in the first four days before ICU admission on prognosis and clinical outcomes in the validation set. by Jie Zhao (49409)

Rut alleviated BBB damage in MCAO rats and exerted neuroprotective effects. by Zhixuan Huang (6750410)

Effect of Rut on neuronal injury caused by OGD. by Zhixuan Huang (6750410)

Impact of red blood cell-platelet ratio trajectories on prognosis and clinical outcomes in the first four days before ICU admission in the training set. by Jie Zhao (49409)

Glucagon-like peptide-1 receptor agonists, inflammation, and kidney diseases: evidence from Mendelian randomization by Yu-Xuan Yao (21338594)

“…</p> <p>After meta-analyses of both discovery and validation cohorts, genetically proxied GLP1R agonist was found to significantly associated with a decreased risk of diabetic nephropathy (OR = 0.72, 95%CI = 0.54–0.97, <i>p</i> = 0.031) and IgA nephropathy (OR = 0.58, 95%CI = 0.36–0.94, <i>p</i> = 0.027). …”